The OASIS-HAE study is a phase 3 clinical trial evaluating the safety and efficacy of donidalorsen, an investigational drug, being studied for the prevention of HAE attacks. The OASIS-HAE study is being conducted to help address the need for new therapies for HAE.
OASIS-HAE will enroll 84 participants and will take place in several countries, including countries in North American and Europe.
Find a Study Clinic
Find an OASIS-HAE study clinic near you.
Sites are located in the cities/states identified with the red pin: